Literature DB >> 5776548

Hodgkin's disease: histological classification and diagnosis.

R M Cross.   

Abstract

A review of the previous histological classifications of Hodgkin's disease seems to show that they are insufficiently accurate in regard to prognosis and difficult to apply but a detailed study of a large number of cases suggests that certain criteria allow of subdivision of the disease into types. These criteria are the proportion of mature lymphocytes, the presence of plentiful mature histiocytes, the presence of fibrous nodularity, and the numbers of abnormal reticulum cells and their degree of anaplasia. Three primary histological subdivisions seem to arise from a study of 302 patients, namely, the reticular, histiocytic, and nodular sclerosis groups. These are further divided into well differentiated and poorly differentiated on the basis of their lymphocyte content and the degree of anaplasia of the abnormal reticulum cells. The histological appearances of each type are described. The application of this histological classification has been shown to correlate well with the clinical outcome.

Entities:  

Mesh:

Year:  1969        PMID: 5776548      PMCID: PMC474028          DOI: 10.1136/jcp.22.2.165

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  13 in total

Review 1.  HODGKIN'S DISEASE--PROGNOSIS, TREATMENT AND ETIOLOGIC AND IMMUNOLOGIC CONSIDERATIONS.

Authors:  A C AISENBERG
Journal:  N Engl J Med       Date:  1964-03-19       Impact factor: 91.245

2.  HISTOLOGICAL CLASSIFICATION AND SURVIVAL IN HODGKIN'S DISEASE; A STUDY OF 251 CASES WITH SPECIAL REFERENCE TO NODULAR SCLEROSING HODGKIN'S DISEASE.

Authors:  T A HANSON
Journal:  Cancer       Date:  1964-12       Impact factor: 6.860

3.  Prognosis in tumors of lymphoid tissue; an analysis of 602 cases.

Authors:  G LUMB; K A NEWTON
Journal:  Cancer       Date:  1957 Sep-Oct       Impact factor: 6.860

4.  Hodgkin's paragranuloma.

Authors:  C J WRIGHT
Journal:  Cancer       Date:  1956 Jul-Aug       Impact factor: 6.860

5.  Mortality in relation to histologic type in Hodgkin's disease.

Authors:  H F SMETANA; B M COHEN
Journal:  Blood       Date:  1956-03       Impact factor: 22.113

6.  A clinicopathological study of nodular sclerosing Hodgkin's disease.

Authors:  R M Cross
Journal:  J Clin Pathol       Date:  1968-05       Impact factor: 3.411

7.  The staging of Hodgkin's disease.

Authors:  D A Karnofsky
Journal:  Cancer Res       Date:  1966-06       Impact factor: 12.701

8.  Histologic classification of Hodgkin's disease.

Authors:  K O Franssila; T V Kalima; A Voutlainen
Journal:  Cancer       Date:  1967-10       Impact factor: 6.860

9.  Benign Hodgkin's disease (Hodgkin's paragranuloma).

Authors:  C V HARRISON
Journal:  J Pathol Bacteriol       Date:  1952-07

10.  A clinicopathological study of benign Hodgkin's disease.

Authors:  P J DAWSON; C V HARRISON
Journal:  J Clin Pathol       Date:  1961-05       Impact factor: 3.411

View more
  7 in total

1.  The pathologic manifestations of Hodgkin's disease.

Authors:  R J Lukes
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1972

2.  Nomenclatures in medicine.

Authors:  J Kennedy; C E Kossmann
Journal:  Bull Med Libr Assoc       Date:  1973-04

3.  Eosinophil predominance in Hodgkin's disease.

Authors:  J Tóth; O Dworák; J Sugár
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1977-05-20

4.  A combined clinical and histological assessment of survival of patients with Hodgkin's disease.

Authors:  R M Cross; F W Dixon
Journal:  J Clin Pathol       Date:  1971-07       Impact factor: 3.411

5.  Rectal biopsy as a prognostic guide in Crohn's colitis.

Authors:  M Ward; J N Webb
Journal:  J Clin Pathol       Date:  1977-02       Impact factor: 3.411

6.  Do lymphocytes protect the rheumatoid joint?

Authors:  K D Muirden; K W Mills
Journal:  Br Med J       Date:  1971-10-23

7.  Hodgkin's disease. A clinico-pathological study of 250 cases with a 5-year follow-up.

Authors:  K A Newton; D H Mackenzie; M F Spittle; A Mikolajczuk
Journal:  Br J Cancer       Date:  1973-01       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.